Home > Income Statement > SENORES PHARMACEUTICALS

SENORES PHARMACEUTICALS
Revenue

    Back to Income Statement
SENORES PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SENORES PHARMACEUTICALS
Please provide your vote to see the results

SENORES PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹398 Cr₹215 Cr₹353 Cr₹14 Cr₹14 Cr

What is the latest Revenue of SENORES PHARMACEUTICALS ?

The latest Revenue ratio of SENORES PHARMACEUTICALS is ₹398 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹398 Cr
Mar2025₹215 Cr
Mar2024₹353 Cr
Mar2023₹14 Cr
Mar2022₹14 Cr

How is Revenue of SENORES PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹398 Cr
85.65
Mar2025 ₹215 Cr
-39.29
Mar2024 ₹353 Cr
2,393.79
Mar2023 ₹14 Cr
0.00
Mar2022 ₹14 Cr -

Compare Revenue of peers of SENORES PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SENORES PHARMACEUTICALS ₹5,420.9 Cr 3.5% -10.8% 55.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,073.0 Cr 7.3% 8.4% 13.1% Stock Analytics
DIVIS LABORATORIES ₹307,147.0 Cr 15.3% 24.1% 63% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,626.0 Cr 1% 2.5% 33.4% Stock Analytics
DR REDDYS LABORATORIES ₹115,685.0 Cr 1% 15.9% 14% Stock Analytics
CIPLA ₹113,589.0 Cr 0.4% 7.9% -6.2% Stock Analytics


SENORES PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SENORES PHARMACEUTICALS

3.5%

-10.8%

55.6%

SENSEX

5.5%

13.3%

-3.4%


You may also like the below Video Courses